Abstract
Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have